LogicBio Therapeutics, Inc. Earnings Per Share (Diluted)
LogicBio Therapeutics, Inc. reported Earnings Per Share (Diluted) of -$0.18 per share for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2022-11-14
- LogicBio Therapeutics, Inc. earnings per share, diluted for the quarter ending 2022-09-30 was -$0.18.
- LogicBio Therapeutics, Inc. earnings per share, diluted for the quarter ending 2022-06-30 was -$0.15.
- LogicBio Therapeutics, Inc. earnings per share, diluted for the quarter ending 2021-09-30 was -$0.31.
- LogicBio Therapeutics, Inc. earnings per share, diluted for the quarter ending 2021-06-30 was -$0.33.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month |
|---|---|---|---|
| 2022-09-30 | -$0.18 10-Q · filed 2022-11-14 | -$0.33 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.53 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$0.15 10-Q · filed 2022-08-15 | -$0.36 10-Q · filed 2022-08-15 | |
| 2021-09-30 | -$0.31 10-Q · filed 2022-11-14 | -$0.64 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.96 10-Q · filed 2022-11-14 |
| 2021-06-30 | -$0.33 10-Q · filed 2022-08-15 | -$0.65 10-Q · filed 2022-08-15 |